Brief: Bio-Path Receives Third U.S. Patent Grant Related To Manufacture Of Platform Technology
10/02/2021 12:06
Feb 10 (Reuters) - Bio Path Holdings Inc BPTH.O :
* BIO-PATH RECEIVES THIRD U.S. PATENT GRANT RELATED TO
MANUFACTURE
OF PLATFORM TECHNOLOGY
Source text for Eikon: ID:nGNX1c9gs7
Further company coverage: BPTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Path Holdings
See all newsBrief: Bio-Path Holdings Seeks Financing For Turnaround & Strategic Actions
Brief: Bio-Path Holdings Reports Full Year 2024 Financial Results
Brief: Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Brief: Bio-Path Provides Key Clinical Updates
Brief: Bio-Path Holdings Provides Update From Phase 1/1B Clinical Trial Of Bp1002 For Treatment Of Refractory/Relapsed Acute Myeloid Leukemia